Inventor · disambiguated record
Jingyuan Ma
Also filed as: MA JINGYUAN
22 granted patents·13 pending applications·148 citations·filing 2005–2022
95Inventor score
Top patents by PatentIndex Score
35 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0294US10934261B2Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Mar 2, 2021·15 cites·44 claims
- 0393US8476308B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Jul 2, 2013·12 cites·6 claims
- 0493US7432394B2Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2006·Granted Oct 7, 2008·12 cites·21 claims
- 0591US8227495B22,4-disubsituted thiazoles and pharmaceutical compositions thereofCHEN XIN·Filed 2009·Granted Jul 24, 2012·13 cites·18 claims
- 0690US7714131B2Process for the stereoselective preparation of (−)-halofenate and derivatives thereofMETABOLEX INC·Filed 2006·Granted May 11, 2010·9 cites·16 claims
- 0789US8288384B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2009·Granted Oct 16, 2012·9 cites·1 claims
- 0886US8183381B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2008·Granted May 22, 2012·13 cites·10 claims
- 0984US8598374B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Dec 3, 2013·6 cites·9 claims
- 1084US8299117B2GPR120 receptor agonists and uses thereofSHI DONG FANG·Filed 2010·Granted Oct 30, 2012·5 cites·6 claims
- 1182US7323480B2Substituted triazoles as modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Jan 29, 2008·6 cites·21 claims
- 1279US7622491B2Modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Nov 24, 2009·4 cites·57 claims
- 1378US9737537B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·2 claims
- 1471US2022324814A1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1567US9925189B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·2 claims
- 1666US11339130B1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2020·Granted May 24, 2022·0 cites·46 claims
- 1765US8309600B2GPR120 receptor agonists and uses thereofSHI DONG FANG·Filed 2009·Granted Nov 13, 2012·0 cites·15 claims
- 1864US8921350B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·0 cites·4 claims
- 1961US8975258B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2012·Granted Mar 10, 2015·0 cites·22 claims
- 2059US2010087468A1Modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2009·Application pending·0 cites
- 2158US2009093650A1Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2008·Application pending·0 cites
- 2256US2014121246A1Gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2013·Application pending·0 cites
- 2356US2015239881A1Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2015·Application pending·0 cites
- 2454US2008108630A1Substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2007·Application pending·0 cites
- 2552US2010216827A1Aryl gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 2650US2011294836A1Aryl gpr119 agonists and uses thereofSONG JIANGAO·Filed 2009·Application pending·0 cites
- 2747US8846675B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2012·Granted Sep 30, 2014·0 cites·22 claims
- 2841US2006014785A1Bicyclic, substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2005·Application pending·0 cites
- 2940US9593109B2Bicyclic agonists of GPR131 and uses thereofSONG JIANGAO·Filed 2012·Granted Mar 14, 2017·0 cites·20 claims
- 3040US2011313160A1Preparation of 5-ethyl-2--pyrimidineCHEN XIN·Filed 2011·Application pending·0 cites
- 3140US2021347727A1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3239US11292801B2Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Apr 5, 2022·0 cites·22 claims
- 3337US8703776B2Agonists of GPR131 and uses thereofNOVACK AARON ROBERT·Filed 2012·Granted Apr 22, 2014·0 cites·20 claims
- 3436US2012184572A1Aryl gpr119 agonists and uses thereofSONG JIANGAO·Filed 2011·Application pending·0 cites
- 3536US2011160222A1Modulators of glucose homeostasis for the treatment of diabetes and metabolic disordersMETABOLEX INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jingyuan Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →